J. Strohalm

6.1k citations

90 papers · 5.2k indexed · h-index 40

Impact in

Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Polymers and Plastics top 2%
- Dendrimers and Hyperbranched Polymers

Papers in ⓘ

Biomaterials 31
- Nanoparticle-Based Drug Delivery 27
Radiology, Nuclear Medicine and Imaging 28
- Radiopharmaceutical Chemistry and Applications 17
- Monoclonal and Polyclonal Antibodies Research 13

Co-authors: Karel Ulbrich (79 shared papers)Ruth Duncan (22 shared papers)Blanka Řı́hová (41 shared papers)Vladimír Šubr (29 shared papers)Leonard W. Seymour (9 shared papers)Jindřich Kopeček (17 shared papers)Jindřich Kopeček (2 shared papers)Tomáš Etrych (23 shared papers)
Journals: Journal of Controlled Release (26 papers)Journal of drug targeting (7 papers)Bioconjugate Chemistry (4 papers)British Journal of Cancer (4 papers)Macromolecular Symposia (4 papers)
Partner nations: Czechia United Kingdom United States

In The Last Decade

J. Strohalm

90 papers receiving 5.1k citations

Peers

Countries citing papers authored by J. Strohalm

Since Specialization

Citations

This map shows the geographic impact of J. Strohalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Strohalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Strohalm more than expected).

Fields of papers citing papers by J. Strohalm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Strohalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Strohalm. The network helps show where J. Strohalm may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Strohalm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Strohalm Line = papers co-authored together J. Strohalm links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues Japanese Journal of Cancer Research ·Youichiro Noguchi, Jun Wu, Ruth Duncan, J. Strohalm, Karel Ulbrich, Takaaki Akaike, Hiroshi Maeda	1998	370
2	Effect of molecular weight (M_w) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats Journal of Biomedical Materials Research ·Leonard W. Seymour, Ruth Duncan, J. Strohalm, Jindřich Kopeček	1987	345
3	Polymeric drugs based on conjugates of synthetic and natural macromolecules Journal of Controlled Release ·Karel Ulbrich, Vladimír Šubr, J. Strohalm, D Plocová, M. Jelı́nková, B Řı́hová	2000	306
4	Polyelectrolyte Vectors for Gene Delivery: Influence of Cationic Polymer on Biophysical Properties of Complexes Formed with DNA Bioconjugate Chemistry ·Margreet A. Wolfert, Philip R. Dash, O. V. Nazarova, David Oupický, Leonard W. Seymour, Sarah Smart, J. Strohalm, Karel Ulbrich	1999	206
5	Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin Biomaterials ·(unknown), Martin Bilej, Václav Větvička, Karel Ulbrich, J. Strohalm, Jindřich Kopeček, Ruth Duncan	1989	177
6	Preclinical evaluation of polymer-bound doxorubicin Journal of Controlled Release ·Ruth Duncan, Leonard W. Seymour, K.B. O'Hare, Pauline A. Flanagan, Stephen R. Wedge, Isabella C. Hume, Karel Ulbrich, J. Strohalm, Vladimír Šubr, F. Spreafico, Maria Grandi, Marina Ripamonti, M. Farao, Antonino Suarato	1992	158
7	Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacy Journal of Controlled Release ·Tomáš Etrych, Lubomír Kovář, J. Strohalm, Petr Chytil, Blanka Řı́hová, Karel Ulbrich	2011	150
8	Poly[N‐(2‐hydroxypropyl)methacrylamide]. IV. Heterogeneous polymerization Die Angewandte Makromolekulare Chemie ·J. Strohalm, Jindřich Kopeček	1978	150
9	Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro British Journal of Cancer ·Ruth Duncan, Pavla Kopečkova—Rejmanová, J. Strohalm, Isabella C. Hume, HC Cable, Jan Pohl, JB Lloyd, Jindřich Kopeček	1987	147
10	Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma British Journal of Cancer ·Leonard W. Seymour, Karel Ulbrich, Peter S. Steyger, M. Brereton, Vladimír Šubr, J. Strohalm, Ruth Duncan	1994	138
11	Decreased Binding to Proteins and Cells of Polymeric Gene Delivery Vectors Surface Modified with a Multivalent Hydrophilic Polymer and Retargeting through Attachment of Transferrin Journal of Biological Chemistry ·Philip R. Dash, Martin L. Read, Kerry Fisher, Kenneth A. Howard, Margreet A. Wolfert, David Oupický, Vladimír Šubr, J. Strohalm, Karel Ulbrich, Leonard W. Seymour	2000	129
12	HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity Journal of Controlled Release ·Tomáš Etrych, Vladimír Šubr, J. Strohalm, Milada Šírová, Blanka Řı́hová, Karel Ulbrich	2012	124
13	The pharmacokinetics of polymer-bound adriamycin Biochemical Pharmacology ·Leonard W. Seymour, Karel Ulbrich, J. Strohalm, Jindřich Kopeček, Ruth Duncan	1990	104
14	Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia British Journal of Cancer ·Ruth Duncan, Pavla Kopečková, J. Strohalm, IC Hume, JB Lloyd, Jindřich Kopeček	1988	103
15	Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody Clinical Immunology and Immunopathology ·Blanka Řı́hová, Pavla Kopečková, J. Strohalm, P Roßmann, Václav Větvička, Jindřich Kopeček	1988	99
16	N-(2-Hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice British Journal of Cancer ·Leonard W. Seymour, Karel Ulbrich, Stephen R. Wedge, Isabella C. Hume, J. Strohalm, Ruth Duncan	1991	94
17	Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo Journal of Controlled Release ·Ruth Duncan, Isabella C. Hume, Pavla Kopečková, Karel Ulbrich, J. Strohalm, Jindřich Kopeček	1989	93
18	Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting European Journal of Pharmaceutical Sciences ·Tomáš Etrych, J. Strohalm, Petr Chytil, Peter Černoch, Larisa Starovoytová, Michal Pechar, Karel Ulbrich	2011	92
19	Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo Journal of Controlled Release ·Vladimír Šubr, J. Strohalm, Karel Ulbrich, Ruth Duncan, Isabella C. Hume	1992	87
20	Polymeric drugs based on conjugates of synthetic and natural macromolecules. Journal of Controlled Release ·Blanka Řı́hová, M. Jelı́nková, J. Strohalm, Vladimír Šubr, D Plocová, Ondřej Hovorka, Mario Novak, D Plundrová, Y Germano, Karel Ulbrich	2000	85

About J. Strohalm

J. Strohalm is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Oncology, Polymers and Plastics and Biotechnology, having authored 90 papers that have together received 5.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (27 papers), RNA Interference and Gene Delivery (17 papers), Radiopharmaceutical Chemistry and Applications (17 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Immunotherapy and Immune Responses (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Biomaterials (2.7k citations), Polymers and Plastics (689 citations), Molecular Medicine (224 citations), Pharmaceutical Science (253 citations) and Organic Chemistry (1.0k citations). J. Strohalm has collaborated with scholars based in Czechia, United Kingdom and United States. Frequent co-authors include Karel Ulbrich, Ruth Duncan, Blanka Řı́hová, Vladimír Šubr, Leonard W. Seymour, Jindřich Kopeček, Jindřich Kopeček, Tomáš Etrych, D Plocová and M. Jelı́nková. Their work appears in journals such as Journal of Controlled Release, Journal of drug targeting, Bioconjugate Chemistry, British Journal of Cancer and Macromolecular Symposia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact